Journal Information
Vol. 36. Issue 2.
Pages 61-63 (February 2000)
Vol. 36. Issue 2.
Pages 61-63 (February 2000)
Full text access
Monitorización de fármacos antituberculosos. ¿Tiene utilidad en la clínica?
Visits
8872
Servicio de Neumología. Hospital Vall d’Hebron. Barcelona
This item has received
Article information
Full text is only aviable in PDF
Bibliografía
[1.]
Pou L, Campos F. A clinical chemistry therapeutic drug monitoring service. En: Decker, editor. Recent developments in therapeutic drug monitoring, clinical toxicology. I Sunshine (ed.) Palo Alto, California, 1992, 9-13.
[2.]
C.A. Peloquin, R. Namdar, M.D. Singleton, D.E. Nix.
Pharmacokinetics of rifampin under fasting conditions, with food, and with antacids.
Chest Med, 115 (1999), pp. 12-18
[4.]
C.A. Peloquin.
Therapeutic drug monitoring in antituberculosis chemotherapy.
Ther Drug Monit, 21 (1999), pp. 426-427
[6.]
C.A. Peloquin.
Therapeutic drug monitoring: principles and application in mycobacterial infections.
Drug Ther, 22 (1992), pp. 31-36
[7.]
S.E. Berning, G.A. Huitt, M.D. Iseman, C.A. Peloquin.
Malabsorption of antituberculosis medications by a patient with AIDS.
N Engl J Med, 327 (1992), pp. 1817-1818
[8.]
K.B. Patel, R. Belmonte, H.M. Crowe.
Drug malabsorption and resistant tuberculosis in HIV-infected patients.
N Engl J Med, 332 (1995), pp. 336-337
[9.]
M. Lutfey, P. Della-Lata, V. Kapur.
Independent origin of mono-rifampin- resistant Mycobacterium tuberculosis in patients with AIDS..
Am J Respir Crit Care Med, 153 (1996), pp. 837-840
[10.]
M.L. De Souza, M. Miravitlles, I. Andrés, F. Nicolau, L. Pou, R. Vidal.
Monitorización de las concentraciones plasmáticas de fármacos antituberculosos.
Estudio piloto. Arch Bronconeumol, 34 (1998), pp. 12
[11.]
J. Sahai, K. Gallicano, L. Swick, S. Tailor, G. Garber, I. Seguin, et al.
Reduced plasma concentrations of antituberculosis drugs in patients with HIV infection.
Ann Intern Med, 127 (1997), pp. 289-293
[12.]
S. Choudhri, M. Hawken, S. Gathua, G. Minyri, W. Watkins, J. Sahai, et al.
Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis AIDS, and diarrhea..
CID, 25 (1997), pp. 104-111
[13.]
M. Kimerling, P. Phillips, P. Patterson, M. Hall, A. Robinson, N. Dunlap.
Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients.
Chest, 113 (1998), pp. 1178-1183
[14.]
B. Taylor, P. Smith.
Does AIDS impair the absorption of antituberculosis agents?.
Int J Tuberc Lung Dis, 2 (1998), pp. 670-675
Copyright © 2000. Sociedad Española de Neumología y Cirugía Torácica